NCT03553771View on ClinicalTrials.gov

Safety and Efficacy of the LVIS and LVIS JR Devices in the Endovascular Treatment of Intracranial Aneurysms

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Intracranial Aneurysm
Interventions
DEVICE

LVIS and LVIS JR

Braided coil assist stents used for aneurysm embolization

Trial Locations (20)

Unknown

CHU Pellgrin, Bordeaux

CHU Caen, Caen

CHU Gabriel Montpied, Clermont-Ferrand

CHU Michallon, Grenoble

Hôpital Bicêtre, Le Kremlin-Bicêtre

CHU Limoges, Limoges

Hôpital Clairval, Marseille

Hôpital de la Timone, Marseille

Hôpital Gui de Chauliac, Montpellier

Hôpital Central de Nancy, Nancy

Hôpital Pasteur 2, Nice

Hôpital Lariboisière, Paris

Hôpital Pitié-Salpêtrière, Paris

La Fondation Rothschild, Paris

Hôpital Maison Blanche, Reims

Hôpital Nord, Saint-Etienne

Hôpital Foch, Suresnes

Hôpital d'instruction des Armées Saint-Anne, Toulon

Hôpital Purpan, Toulouse

Hôpital Bretonneau, Tours

Sponsors

Collaborators (1)

Clinact
All Listed Sponsors
collaborator

Clinact

OTHER

lead

Microvention-Terumo, Inc.

INDUSTRY

NCT03553771 - Safety and Efficacy of the LVIS and LVIS JR Devices in the Endovascular Treatment of Intracranial Aneurysms | Biotech Hunter | Biotech Hunter